Oklo Inc. (OKLO) Stock Analysis and Metrics

Oklo

NYSE: OKLO

$40.97 ▲ +0.72 (+1.79%)

At close: Jul 27, 2026 · 2:25 PM UTC

Financial Ratios

Market Cap6.97 Bn

P/E-54.08

Div. Yield0.00

Add ratio to table…

About

Oklo Inc. develops advanced fission power plants called powerhouses that generate electricity and heat. The company also pursues nuclear fuel recycling to convert used nuclear fuel into usable fuel for its powerhouses and for other reactors. Through its subsidiary Atomic Alchemy Oklo produces radioisotopes for medical energy industrial defense and artificial intelligence applications.

Oklo Inc. intends to earn revenue primarily by selling electricity and heat under long term power purchase agreements with customers such as data centers utilities and government facilities. The company also generates income from the sale of radioisotopes produced by Atomic Alchemy for medical research and industrial uses. Future revenue may arise from operating nuclear fuel recycling facilities that process used fuel into fresh reactor feed.

Oklo Inc. operates in a niche of the nuclear energy sector that focuses on small modular fast fission reactors ranging from 15 to 75 megawatts electric with potential to scale to 100 megawatts electric or higher. Its competitors include large traditional baseload power providers such as coal and natural gas plants other advanced reactor developers like high temperature gas and molten salt projects and renewable energy firms offering wind solar or storage solutions. Oklo differentiates itself by combining reactor design construction ownership and operation under one business model which allows it to capture full lifecycle value and to use recycled nuclear fuel to lower fuel costs and enhance sustainability.

Oklo Inc. has engaged a diverse set of prospective customers spanning technology infrastructure energy and defense sectors. Specific agreements include a prepayment arrangement with Meta Platforms Inc. to support a 1.2 gigawatt power campus in Ohio and non binding letters of intent with Equinix Inc. Diamondback Energy and Prometheus Hyperscale. The company has also signed a 12 gigawatt master power agreement with Switch Ltd. and is in discussions with the Tennessee Valley Authority for fuel recycling and power sales. Additionally Oklo has been selected to potentially supply electricity and heat to Eielson Air Force Base in Alaska.

Investment Thesis

▲ Bull case

Oklo has positioned itself to capitalize on the U.S. Department of Energy's Surplus Plutonium Utilization Program, which provides access to approximately 20 metric tons of plutonium from Cold War-era warheads—a resource equivalent to 160–200 tons of High-Assay Low-Enriched Uranium (HALEU) in fuel potential. This abundance of readily available fuel material allows Oklo to bypass years-long delays associated with scaling domestic enrichment infrastructure and HALEU supply chains, directly enabling faster deployment of its Aurora powerhouses at Ohio and Eielson. The company's fast reactor technology is uniquely suited to utilize plutonium as a bridge fuel, mixing it with uranium and zirconium to form ternary alloy fuel—a proven approach with deep historical backing in U.S. fast reactor R&D. This strategy is not theoretical; Oklo has already advanced partnerships with newcleo, Los Alamos National Laboratory, and NVIDIA to validate and optimize plutonium-bearing fuel fabrication, creating a de-risked pathway to commercial-scale fuel production. By leveraging surplus plutonium, Oklo can initiate reactor operations sooner than competitors dependent on immature HALEU supply, translating into earlier revenue generation from power sales and isotope production while reducing near-term fuel sourcing risk—a structural advantage the market may be underestimating amid broader nuclear deployment optimism. Oklo
The convergence of regulatory modernization (NRC Part 57), DOE authorization pathways, and Oklo's vertically integrated business model creates a compounding catalyst for accelerated deployment that remains underappreciated. Part 57’s fleet-based licensing framework—designed for 6–12 month timelines per reactor—aligns directly with Oklo’s campus-style deployment model (e.g., the 1.2 GW Aurora-Ohio campus with Meta), allowing identical Aurora powerhouses to be licensed en masse rather than individually. This is further amplified by Oklo’s strategy of using DOE-authorized early assets (like Aurora-INL and the Groves test reactor) to generate real-world operating, safety, and engineering data that can inform and streamline subsequent NRC reviews under Part 57, effectively turning initial deployments into regulatory de-risking tools. The Groves facility’s 229-day timeline from groundbreaking to substantial completion demonstrates Oklo’s ability to execute nuclear construction at speeds previously deemed implausible, validating its modular, factory-built approach. When combined with parallel progress in fuel fabrication (A3F at INL), recycling (Tennessee Advanced Fuel Center), and isotope production (Idaho Radiochemistry Laboratory), this integrated model reduces dependency on external suppliers and compresses the critical path from fuel to power to revenue—a systemic efficiency gain that could meaningfully shorten deployment timelines across Oklo’s pipeline beyond current market expectations. Oklo
Oklo’s isotope business, particularly the Idaho Radiochemistry Laboratory, represents a near-term, high-margin revenue stream that is being overlooked amid focus on long-term power projects. The facility has already secured its NRC material handling permit and is actively pursuing its first commercial isotope contract, with management indicating revenue generation could begin in 2026. Isotopes produced here—such as those for radioisotope thermoelectric generators (RTGs), medical diagnostics, and industrial applications—command premium pricing due to their critical use in space, defense, and healthcare sectors, where supply constraints are acute and alternatives are limited. Unlike power plants, which require years of construction and licensing, isotope production can scale rapidly once regulatory approvals are in place, offering a faster cash flow inflection point. Moreover, the isotope segment synergizes with Oklo’s fuel recycling and power operations: recovered materials from used nuclear fuel can be repurposed into valuable isotopes, turning a potential waste stream into a profit center. This vertical integration not only enhances overall asset utilization but also diversifies revenue away from reliance on power purchase agreements alone, providing a stabilizing financial buffer during the capital-intensive build-out of power infrastructure—a dual advantage the market may not be fully pricing in as Oklo scales its execution. Oklo

Oklo has positioned itself to capitalize on the U.S. Department of Energy's Surplus Plutonium Utilization Program, which provides access to approximately 20 metric tons of plutonium from Cold War-era warheads—a resource equivalent to 160–200 tons of High-Assay Low-Enriched Uranium (HALEU) in fuel potential. This abundance of readily available fuel material allows Oklo to bypass years-long delays associated with scaling domestic enrichment infrastructure and HALEU supply chains, directly enabling faster deployment of its Aurora powerhouses at Ohio and Eielson. The company's fast reactor technology is uniquely suited to utilize plutonium as a bridge fuel, mixing it with uranium and zirconium to form ternary alloy fuel—a proven approach with deep historical backing in U.S. fast reactor R&D. This strategy is not theoretical; Oklo has already advanced partnerships with newcleo, Los Alamos National Laboratory, and NVIDIA to validate and optimize plutonium-bearing fuel fabrication, creating a de-risked pathway to commercial-scale fuel production. By leveraging surplus plutonium, Oklo can initiate reactor operations sooner than competitors dependent on immature HALEU supply, translating into earlier revenue generation from power sales and isotope production while reducing near-term fuel sourcing risk—a structural advantage the market may be underestimating amid broader nuclear deployment optimism. Oklo
The convergence of regulatory modernization (NRC Part 57), DOE authorization pathways, and Oklo's vertically integrated business model creates a compounding catalyst for accelerated deployment that remains underappreciated. Part 57’s fleet-based licensing framework—designed for 6–12 month timelines per reactor—aligns directly with Oklo’s campus-style deployment model (e.g., the 1.2 GW Aurora-Ohio campus with Meta), allowing identical Aurora powerhouses to be licensed en masse rather than individually. This is further amplified by Oklo’s strategy of using DOE-authorized early assets (like Aurora-INL and the Groves test reactor) to generate real-world operating, safety, and engineering data that can inform and streamline subsequent NRC reviews under Part 57, effectively turning initial deployments into regulatory de-risking tools. The Groves facility’s 229-day timeline from groundbreaking to substantial completion demonstrates Oklo’s ability to execute nuclear construction at speeds previously deemed implausible, validating its modular, factory-built approach. When combined with parallel progress in fuel fabrication (A3F at INL), recycling (Tennessee Advanced Fuel Center), and isotope production (Idaho Radiochemistry Laboratory), this integrated model reduces dependency on external suppliers and compresses the critical path from fuel to power to revenue—a systemic efficiency gain that could meaningfully shorten deployment timelines across Oklo’s pipeline beyond current market expectations. Oklo
Oklo’s isotope business, particularly the Idaho Radiochemistry Laboratory, represents a near-term, high-margin revenue stream that is being overlooked amid focus on long-term power projects. The facility has already secured its NRC material handling permit and is actively pursuing its first commercial isotope contract, with management indicating revenue generation could begin in 2026. Isotopes produced here—such as those for radioisotope thermoelectric generators (RTGs), medical diagnostics, and industrial applications—command premium pricing due to their critical use in space, defense, and healthcare sectors, where supply constraints are acute and alternatives are limited. Unlike power plants, which require years of construction and licensing, isotope production can scale rapidly once regulatory approvals are in place, offering a faster cash flow inflection point. Moreover, the isotope segment synergizes with Oklo’s fuel recycling and power operations: recovered materials from used nuclear fuel can be repurposed into valuable isotopes, turning a potential waste stream into a profit center. This vertical integration not only enhances overall asset utilization but also diversifies revenue away from reliance on power purchase agreements alone, providing a stabilizing financial buffer during the capital-intensive build-out of power infrastructure—a dual advantage the market may not be fully pricing in as Oklo scales its execution. Oklo

▼ Bear case

Despite Oklo’s progress in securing surplus plutonium and advancing DOE authorizations, the company remains exposed to significant execution risk in transitioning from Department of Energy (DOE) experimental sites to commercially viable, NRC-licensed power plants—particularly for flagship projects like Aurora-Ohio. While DOE pathways (e.g., Other Transaction Agreements) allow rapid construction and testing at Idaho National Laboratory, they do not confer commercial operating rights; full deployment hinges on obtaining NRC licenses under evolving frameworks like Part 57, which, although finalized, is still undergoing public comment and has no proven track record of successful application to a full-scale advanced reactor like Oklo’s Aurora design. The NRC’s historical caution toward novel reactor technologies means any delay in Part 57 implementation—or unforeseen scrutiny during licensing review—could push back timelines for Aurora-Ohio’s 1.2 GW campus beyond management’s optimistic “months, if not more than a year” PJM interconnection estimate, potentially extending deployment into 2028 or later. Furthermore, Oklo’s reliance on first-of-a-kind DOE-authorized assets (e.g., Aurora-INL) to generate data for future NRC licensing assumes these early deployments will proceed without technical setbacks; however, fast reactor systems using plutonium-uranium-zirconium ternary alloy fuel introduce novel thermal-hydraulic and materials challenges that may only emerge during integrated system testing, risking costly redesigns or delays that could undermine the regulatory de-risking thesis. Oklo
Oklo’s fuel strategy, while seemingly robust with multiple pathways (enrichment partnerships, government surplus plutonium, recycling, and Centrus collaboration), faces material scalability and timing mismatches that could hinder simultaneous deployment across its power, fuel, and isotope verticals. The Surplus Plutonium Utilization Program, though promising, is limited to a finite 20-ton tranche—enough for only a handful of initial reactor cores—meaning Oklo must transition to HALEU or recycled fuel sooner than anticipated to sustain multi-gigawatt deployment like Aurora-Ohio. Yet HALEU supply chains remain nascent, with Centrus and other enrichers still struggling to achieve consistent, cost-effective production at advanced assay levels, and the Tennessee Advanced Fuel Center’s recycling capability is contingent on NRC application approval and site preparation, with no clear timeline for operational readiness. This creates a near-term fuel sourcing gap where Oklo may be forced to rely on spot purchases or delayed enrichment contracts at inflated costs, eroding project economics. Compounding this, the company’s vertical integration model assumes seamless coordination between fuel fabrication (A3F), power production (Aurora-INL/Ohio), recycling, and isotope separation—but any bottleneck in one leg (e.g., delayed DSA approval for A3F or slow isotope offtake) can idle the entire loop, turning a theoretical advantage into an operational liability if internal timelines diverge. Oklo
The market may be overestimating the near-term revenue potential of Oklo’s isotope business, particularly given the long sales cycles, stringent regulatory hurdles, and niche customer base associated with medical and industrial isotopes. While the Idaho Radiochemistry Laboratory holds an NRC material handling permit, securing commercial contracts requires navigating complex buyer qualification processes, quality validation protocols, and long-term supply agreements—especially for high-value applications like radiopharmaceuticals, where customers demand multi-year reliability and fail-safe production histories that a first-of-its-kind facility like Oklo’s cannot yet provide. The pending first commercial isotope contract remains undefined in volume, pricing, and duration, and there is no guarantee it will materialize in 2026 as suggested; delays in customer qualification or technical demonstrations could push revenue onset into 2027 or beyond. Moreover, isotope production depends on a steady feedstock of target materials (e.g., irradiated isotopes from the Groves reactor or fuel recycling stream), which itself is contingent on successful reactor operation and fuel availability—creating a dependency loop where isotope revenue cannot scale until power and fuel operations are stable. Unlike power projects with defined offtake partners like Meta, the isotope market lacks anchor tenants, making early revenue highly speculative and sensitive to execution missteps in upstream operations, a risk the market may be overlooking in its enthusiasm for Oklo’s integrated narrative. Oklo

Despite Oklo’s progress in securing surplus plutonium and advancing DOE authorizations, the company remains exposed to significant execution risk in transitioning from Department of Energy (DOE) experimental sites to commercially viable, NRC-licensed power plants—particularly for flagship projects like Aurora-Ohio. While DOE pathways (e.g., Other Transaction Agreements) allow rapid construction and testing at Idaho National Laboratory, they do not confer commercial operating rights; full deployment hinges on obtaining NRC licenses under evolving frameworks like Part 57, which, although finalized, is still undergoing public comment and has no proven track record of successful application to a full-scale advanced reactor like Oklo’s Aurora design. The NRC’s historical caution toward novel reactor technologies means any delay in Part 57 implementation—or unforeseen scrutiny during licensing review—could push back timelines for Aurora-Ohio’s 1.2 GW campus beyond management’s optimistic “months, if not more than a year” PJM interconnection estimate, potentially extending deployment into 2028 or later. Furthermore, Oklo’s reliance on first-of-a-kind DOE-authorized assets (e.g., Aurora-INL) to generate data for future NRC licensing assumes these early deployments will proceed without technical setbacks; however, fast reactor systems using plutonium-uranium-zirconium ternary alloy fuel introduce novel thermal-hydraulic and materials challenges that may only emerge during integrated system testing, risking costly redesigns or delays that could undermine the regulatory de-risking thesis. Oklo
Oklo’s fuel strategy, while seemingly robust with multiple pathways (enrichment partnerships, government surplus plutonium, recycling, and Centrus collaboration), faces material scalability and timing mismatches that could hinder simultaneous deployment across its power, fuel, and isotope verticals. The Surplus Plutonium Utilization Program, though promising, is limited to a finite 20-ton tranche—enough for only a handful of initial reactor cores—meaning Oklo must transition to HALEU or recycled fuel sooner than anticipated to sustain multi-gigawatt deployment like Aurora-Ohio. Yet HALEU supply chains remain nascent, with Centrus and other enrichers still struggling to achieve consistent, cost-effective production at advanced assay levels, and the Tennessee Advanced Fuel Center’s recycling capability is contingent on NRC application approval and site preparation, with no clear timeline for operational readiness. This creates a near-term fuel sourcing gap where Oklo may be forced to rely on spot purchases or delayed enrichment contracts at inflated costs, eroding project economics. Compounding this, the company’s vertical integration model assumes seamless coordination between fuel fabrication (A3F), power production (Aurora-INL/Ohio), recycling, and isotope separation—but any bottleneck in one leg (e.g., delayed DSA approval for A3F or slow isotope offtake) can idle the entire loop, turning a theoretical advantage into an operational liability if internal timelines diverge. Oklo
The market may be overestimating the near-term revenue potential of Oklo’s isotope business, particularly given the long sales cycles, stringent regulatory hurdles, and niche customer base associated with medical and industrial isotopes. While the Idaho Radiochemistry Laboratory holds an NRC material handling permit, securing commercial contracts requires navigating complex buyer qualification processes, quality validation protocols, and long-term supply agreements—especially for high-value applications like radiopharmaceuticals, where customers demand multi-year reliability and fail-safe production histories that a first-of-its-kind facility like Oklo’s cannot yet provide. The pending first commercial isotope contract remains undefined in volume, pricing, and duration, and there is no guarantee it will materialize in 2026 as suggested; delays in customer qualification or technical demonstrations could push revenue onset into 2027 or beyond. Moreover, isotope production depends on a steady feedstock of target materials (e.g., irradiated isotopes from the Groves reactor or fuel recycling stream), which itself is contingent on successful reactor operation and fuel availability—creating a dependency loop where isotope revenue cannot scale until power and fuel operations are stable. Unlike power projects with defined offtake partners like Meta, the isotope market lacks anchor tenants, making early revenue highly speculative and sensitive to execution missteps in upstream operations, a risk the market may be overlooking in its enthusiasm for Oklo’s integrated narrative. Oklo

Peer Comparison

Companies in the Utilities - Independent Power Producers

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	VST	Vistra Corp.	52.98 Bn	25.86	2.72	17.26 Bn
2	NRG	Nrg Energy, Inc.	28.41 Bn	165.19	0.88	23.15 Bn
3	TLN	Talen Energy Corp	15.71 Bn	-748.03	4.73	6.81 Bn
4	OKLO	Oklo Inc.	6.97 Bn	-54.08	-	-
5	TAC	Transalta Corp	3.96 Bn	-20.63	2.30	2.70 Bn
6	KEN	Kenon Holdings Ltd.	3.64 Bn	28.64	3.62	1.81 Bn
7	DGXX	Digi Power X Inc.	0.26 Bn	-7.34	8.17	-

Research Tools

Developers

About

Investment Thesis

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Peer Comparison

Create an account

Sign In

Reset Password